Polipeptide compounds for inhibiting angiogenesis and tumor growth
Details for Australian Patent Application No. 2005286662 (hide)
International Classifications
Event Publications
10 May 2007 PCT application entered the National Phase
PCT publication WO2006/034455 Priority application(s): WO2006/034455
6 October 2011 Application Accepted
Published as AU-B-2005286662
27 October 2011 Alteration of Name
The name of the applicant has been altered to VasGene Therapeutics, Inc. 2006
10 November 2011 Application for Amendment
The nature of the amendment is: Amend the invention title to read Polypeptide compounds for inhibiting angiogenesis and tumor growth. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
1 March 2012 Amendment Made
The nature of the amendment is: Amend the invention title to read Polypeptide compounds for inhibiting angiogenesis and tumor growth
5 April 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005286663-Compositions and methods for detecting and treating tumors
2005286659-Seat repositioning device with release on control handle
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser